CIK 0001472091
- Non-accelerated filer
- Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264231384
- Phone
- +1 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition Director disposed of 58,476 shares (other)
- 4 Open-market sale Chief Scientific Officer sold 2,500 shares at $16.41 ($41,025)
- 4 Open-market sale Chief Scientific Officer sold 10,000 shares at an average $16.53 ($165,300)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 5,000 shares at an average $14.95 ($74,725)
- 4 Open-market sale President and CEO sold 5,000 shares at an average $15.42 ($77,100)
- 4 Open-market sale Chief Scientific Officer sold 12,500 shares at an average $13.93 ($174,075)
- 4 Open-market sale President and CEO sold 5,000 shares at an average $13.05 ($65,250)
- 4 Derivatives Options or other derivatives
Page 9 of 14 · 272 filings